Bangkok Lab and Cosmetic PCL (BKK:BLC) Other Current Payables: ฿118 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:BLC Bangkok Lab and Cosmetic PCL BKK:BLC
62 GF Score
Price ฿4.08
GF Value ฿5.13
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Bangkok Lab and Cosmetic PCL Other Current Payables?

Bangkok Lab and Cosmetic PCL BKK:BLC +0.99% 62 Other Current Payables is ฿118 Mil as of Mar. 2026. GuruFocus rates BKK:BLC with a GF Score™ of 62/100 and a GF Value™ of ฿5.13 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Bangkok Lab and Cosmetic PCL's Other Current Payables for the quarter that ended in Mar. 2026 was ฿118 Mil.

Bangkok Lab and Cosmetic PCL's quarterly Other Current Payables increased from Sep. 2025 (฿113 Mil) to Dec. 2025 (฿147 Mil) but then declined from Dec. 2025 (฿147 Mil) to Mar. 2026 (฿118 Mil).

Bangkok Lab and Cosmetic PCL's annual Other Current Payables declined from Dec. 2023 (฿65 Mil) to Dec. 2024 (฿64 Mil) but then increased from Dec. 2024 (฿64 Mil) to Dec. 2025 (฿147 Mil).

Bangkok Lab and Cosmetic PCL Other Current Payables Related Terms

Bangkok Lab and Cosmetic PCL Other Current Payables Historical Data

* Premium members only.

The historical data trend for Bangkok Lab and Cosmetic PCL's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bangkok Lab and Cosmetic PCL Other Current Payables Chart

Bangkok Lab and Cosmetic PCL Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
58.63 92.63 64.81 63.70 146.63

Bangkok Lab and Cosmetic PCL Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 90.01 110.93 112.58 146.63 118.31
BKK:BLC
62GF Score
Bangkok Lab and Cosmetic PCL BKK:BLC
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bangkok Lab and Cosmetic PCL Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of ฿118 Mil mean?
Bangkok Lab and Cosmetic PCL (BKK:BLC) has a Other Current Payables of ฿118 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Bangkok Lab and Cosmetic PCL and its competitors.
Is Bangkok Lab and Cosmetic PCL's Other Current Payables too high?
Bangkok Lab and Cosmetic PCL's current Other Current Payables is ฿118 Mil. Overall, Bangkok Lab and Cosmetic PCL has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bangkok Lab and Cosmetic PCL's Other Current Payables compare to PG and CL?
Bangkok Lab and Cosmetic PCL's Other Current Payables of ฿118 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Consumer Packaged Goods company?
A good Other Current Payables depends on the Consumer Packaged Goods industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Bangkok Lab and Cosmetic PCL and its competitors. Bangkok Lab and Cosmetic PCL's current Other Current Payables is ฿118 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bangkok Lab and Cosmetic PCL stock overvalued right now?
Based on GuruFocus' analysis, Bangkok Lab and Cosmetic PCL (BKK:BLC) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿5.13, compared to a current price of ฿4.08 — trading 20.5% below its estimated fair value. The current Other Current Payables is ฿118 Mil. Bangkok Lab and Cosmetic PCL's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Bangkok Lab and Cosmetic PCL (BKK:BLC), the current Other Current Payables is ฿118 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bangkok Lab and Cosmetic PCL (BKK:BLC) Overvalued in 2026?

Based on GuruFocus' analysis, Bangkok Lab and Cosmetic PCL stock appears to be undervalued. The current stock price of ฿4.08 is trading 20.5% below its estimated GF Value™ of ฿5.13. GuruFocus considers Bangkok Lab and Cosmetic PCL to be Modestly Undervalued.

Key valuation signals for BKK:BLC:

  • Other Current Payables: ฿118 Mil
  • GF Value™: ฿5.13 vs. price of ฿4.08 (20.5% below fair value)
  • GF Score™: 62/100 with 2 warning signs

No single metric tells the full story. See the BKK:BLC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bangkok Lab and Cosmetic PCL Business Description

Address Nong Chae Sao Road, No. 48/1 Moo 5, Nam Phu, Mueang Ratchaburi, Ratchaburi, Bangkok, THA, 70000
Bangkok Lab and Cosmetic PCL are one of Thailand's comprehensive healthcare solutions groups. The principal activities of the Group are the manufacturing and distributing of pharmaceuticals and medicinal chemical products for human and animal It operates in a single line of business, namely pharmaceuticals and medicinal chemical products, The Group derives revenue from sales of goods and rendering of services.
62GF Score

Get the complete analysis for BKK:BLC

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿4.08
Price
฿5.13
GF Value